Cover Image
市場調查報告書

全球細胞&細胞為基礎診斷市場:組織學&細胞學,原位雜合反應(ISH)、HPV檢驗、流式細胞技術、數位病理學/圖像分析、血液電池化驗、免疫組織化學(IHC)、CTC、及其他的檢驗

The World Market for Tissue Diagnostics & Cell-Based Diagnostics (Histology & Cytology, In situ hybridization (ISH), HPV Tests, Flow Cytometry, Digital Pathology/Image Cytometry, Hematology Cell Assays, Immunohistochemistry (IHC), CTC & Other Tests)

出版商 Kalorama Information 商品編碼 320681
出版日期 內容資訊 英文 433 Pages
訂單完成後即時交付
價格
Back to Top
全球細胞&細胞為基礎診斷市場:組織學&細胞學,原位雜合反應(ISH)、HPV檢驗、流式細胞技術、數位病理學/圖像分析、血液電池化驗、免疫組織化學(IHC)、CTC、及其他的檢驗 The World Market for Tissue Diagnostics & Cell-Based Diagnostics (Histology & Cytology, In situ hybridization (ISH), HPV Tests, Flow Cytometry, Digital Pathology/Image Cytometry, Hematology Cell Assays, Immunohistochemistry (IHC), CTC & Other Tests)
出版日期: 2014年11月20日 內容資訊: 英文 433 Pages
簡介

本報告以全球組織、細胞診斷壓制政治、技術為焦點,提供全球組織、細胞診斷市場規模、各技術的銷售額、各地區的市場分析,及主要企業簡介等彙整,為您概述為以下內容。

第1章 摘要整理

第2章 簡介

  • 組織、細胞診斷概要
  • 細胞學、細胞學
  • 組織、細胞診斷
  • 見解

第3章 組織、細胞分析技術

  • 檢驗樣品的種類
  • 顯微鏡檢驗
  • 細胞化驗分析:行動電話成像系統及高內涵篩選(HCS)
  • 血液分析儀
  • 染色劑
  • 免疫組織化學(IHC)
  • 流式細胞技術
  • 染色體分析
  • 組織、在組織裡存在的核酸的分子診斷分析
  • 螢光原位雜合技術(FISH)
  • 組織檢驗樣品的生物標記檢測的聚合酵素鏈鎖反應(PCR)
  • 基因表現模式分析(「遺傳基因特徵」)
  • 次世代定序
  • 組織微陣列
  • 循環腫瘤細胞(CTC)
  • 數位病理學、圖像分析
  • 組織學實驗室自動化
  • 質譜分析:成像、DNA分析

第4章 組織、細胞診斷應用

  • 研究、藥物研發及開發
  • 體外診斷

第5章 疾病應用:組織、細胞診斷

  • 癌症
  • 癌症篩檢:子宮頸抹片及人類乳突病毒(HPV)檢驗
  • 癌症的診斷
  • 藥理診斷(Pharmacodiagnostics)
  • 產前檢查
  • 組織、細胞診斷的其他疾病應用

第6章 契約:組織/細胞診斷企業

  • 組織、細胞診斷企業的投資、財務協定
  • 其他企業的協議
  • 組織、細胞診斷企業的收購
  • 其他主要協定

第7章 組織/細胞診斷:市場成長的促進要素、課題

  • 組織/細胞診斷市場促進要素
  • 進行到研究企業銷售的企業所面臨的課題、障礙
  • 體外診斷企業所面臨的課題、障礙
  • 對小型切片檢查標本的實驗數的增加
  • 未來展望

第8章 市場分析

  • 組織、細胞診斷市場:各技術
  • 組織、細胞診斷市場:各地區的分佈
  • 組織、細胞診斷市場:各疾病的徵兆
  • 組織、細胞診斷:CLIA認證企業的獨自檢驗
  • 實驗室
  • 生命科學的組織、細胞分析
  • 組織、細胞診斷市場成長展望

第9章 企業簡介:組織診斷產品或服務的行銷或開發企業

  • 20/20 GeneSystems, Inc.
  • 3DHISTECH Ltd.
  • Abbott Laboratories
  • Abcam plc
  • AB SCIEX (A Danaher Corporation company)
  • Adaptive Biotechnologies Corporation
  • AdnaGen GmbH (An Alere Company)
  • Advanced Cell Diagnostics
  • Affymetrix, Inc.
  • Agena Bioscience Inc.
  • Agendia BV
  • Agilent Technologies Inc.
  • Amoy Diagnostics Co. Ltd.
  • Angle plc
  • ApoCell, Inc.
  • Apogee Flow Systems Ltd.
  • Apollo PACS, Inc.
  • Applied Cytometry
  • Applied Spectral Imaging, Inc.
  • Arbor Vita Corporation
  • Asuragen, Inc.
  • Aurora Interactive
  • AutoGenomics, Inc.
  • Aviva BioSciences Corporation
  • Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
  • Becton Dickinson and Co. (BD)
  • Biocare Medical, LLC
  • Biocartis S.A.
  • Biocep Ltd
  • Biocept, Inc.
  • Biodot Inc.
  • BioFluidica, Inc.
  • BioGenex
  • BioMarker Strategies
  • bioMerieux SA
  • BioMosaics Inc.
  • Bio-Rad Laboratories, Inc.
  • Bio SB
  • BioTek Instruments, Inc.
  • bioTheranostics (A bioMerieux company)
  • BioView Ltd.
  • Bruker Corporation
  • Cancer Genetics, Inc.
  • Canopus Bioscience Ltd.
  • Caris Life Sciences
  • Carl Zeiss AG
  • Castle Biosciences Inc.
  • CCC Diagnostics, LLC
  • CDx Diagnostics
  • Celerus Diagnostics, Inc.
  • CellaVision AB
  • CellTraffix, Inc.
  • Cellular Dynamics International
  • Celula, Inc.
  • Cernostics
  • Cirdan Imaging Ltd
  • Cisbio Bioassays
  • Clarient Diagnostic Services (A GE Healthcare Company)
  • Clearbridge BioMedics
  • Clontech Laboratories, Inc. (Member of the Takara Bio Group)
  • CombiMatrix Corporation
  • Creatv MicroTech, Inc.
  • Cymogen Dx, LLC (Being Acquired by Biocare Medical LLC)
  • Cynvenio Biosystems, Inc.
  • Cytek Development Inc.
  • CytoTrack ApS
  • Dako A/S (An Agilent Technologies Company)
  • Danaher Corporation
  • Definiens AG
  • DiaCarta Inc.
  • DiaTech Oncology
  • DiscoveRx Corporation
  • Elitech Group
  • EMD Millipore (Merck Millipore)
  • Enzo Biochem, Inc.
  • Epic Sciences, Inc.
  • Fluidigm Corporation
  • Fluxion Biosciences, Inc.
  • Foundation Medicine, Inc.
  • GE Healthcare
  • GeneCentric Diagnostics, Inc.
  • Genomic Health, Inc.
  • HemoGenix
  • HistoGeneX
  • Hologic, Inc.
  • HORIBA Medical
  • HTG Molecular Diagnostics
  • Huron Technologies International Inc.
  • Icellate AB
  • Ikonisys, Inc.
  • ImaBiotech SAS
  • IMMCO Diagnostics (A Trinity Biotech Company)
  • IncellDx, Inc.
  • Indica Labs, Inc.
  • Insight Genetics, Inc.
  • IntelliCyte Corporation
  • Iris BioTechnologies Inc.
  • Janssen Diagnostics
  • Leica Biosystems Inc. (Part of Danaher Corporation)
  • Leica Microsystems (A Danaher Company)
  • LeucoDx Inc.
  • Life Technologies Corporation (Acquired by Thermo Fisher Scientific Inc.)
  • MDxHealth SA
  • Metamark Genetics, Inc.
  • MetaSystems GmbH
  • Miltenyi Biotec GmbH
  • Molecular Devices, LLC (A Danaher Company)
  • MolecularMD Corporation
  • Monogram Biosciences (LabCorp Specialty Testing Group)
  • Multiplicom N.V.
  • Myriad Genetics, Inc.
  • NanoString Technologies, Inc.
  • Nikon Corporation/Nikon Instruments Inc.
  • Nodality, Inc.
  • Norchip AS
  • Olympus Group
  • Omnyx
  • OncoHealth Corp.
  • OncoPlex Diagnostics (OncoPlexDx)
  • Oxford Cancer Biomarkers Ltd.
  • Oxford Gene Technology
  • Panagene Inc.
  • PerkinElmer, Inc.
  • Protea Biosciences Group, Inc.
  • Qiagen N.V.
  • QuanDx
  • QuantuMDx Group
  • Rarecells SAS
  • Response Genetics, Inc.
  • Rheonix, Inc.
  • Roche Diagnostics
  • ScreenCell
  • Siemens Healthcare Diagnostics
  • Sigma-Aldrich Corporation
  • Silicon Biosystems
  • Sony Biotechnology Inc.
  • Span Diagnostics Ltd.
  • Sysmex Corporation
  • TeloVISION, LLC
  • Theranostics Health Inc.
  • Thermo Fisher Scientific, Inc.
  • Ventana Medical Systems Inc. (Member of the Roche Group)
  • Veracyte, Inc.
  • Vitatex Inc.
  • WaveSense, Inc.

圖表

目錄
Product Code: KLI5389372

The field of tissue and cell diagnostics includes many traditional technologies, some of which have been used for decades. In addition many new technologies developed for other applications are now being applied in this field. These include mass spectrometry and next generation DNA sequencing. Advances in tissue/cell technologies are also being developed, such as detection, capture, and analysis of circulating tumor cells (CLCs). All of the technologies and applications discussed in The World Market for Tissue and Cell-Based Diagnostics share the characteristic that they start with tissue or cell specimens.

This report focuses on tissue and cell diagnostic assays and technologies, providing the world markets for tissue and cell diagnostics in U.S. dollars for 2013 to 2018. Worldwide sales are indicated by type of technology, including:

  • Traditional Histology
  • HPV Tests
  • Flow Cytometry
  • Digital Pathology/Image Cytometry
  • Circulating tumor cells (CTCs)
  • Hematology (cell assays)
  • In situ hybridization (ISH)
  • Immunohistochemistry (IHC)
  • Stains [non-Pap]
  • Pap Smear

Tissue/cell diagnostics sales are indicated by geographical region for 2013 and 2018, covering:

  • North America
  • Europe
  • Asia
  • Rest of World

Historically, histology and cytology work had been highly labor intensive and subjective in nature. At least this was the scenario for this market segment before the commercialization of automation and digital image analysis, and before the introduction of automated molecular diagnostic assays for cancer gene mutations and for infectious agents such as HPV.

The World Market for Tissue and Cell-Based Diagnostics covers the advances in research, and in drug discovery and development, that are fueling growth in clinical applications of tissue and cell diagnostics. This is a rapidly growing market that is being fueled by growth in HPV testing (outside the U.S.), the growing number of targeted therapies being developed for treatment of cancer, the growth of companion diagnostic tests for these new cancer therapies, automation of the histology laboratory (making it possible to perform more assays), and advances that make it possible to develop tests to address other important questions such as how aggressive a patient's tumor is likely to be. Flow cytometry platforms have been available for many years. Now other areas of histology and cytology are following the trend already in action in other segments of the in vitro diagnostics (IVD) market. From slide preparation through analysis, all the way to result reporting, combined and automated solutions enable faster turn-around time while providing standardized results.

The report profiles key companies in the industry, including:

  • 20/20 GeneSystems, Inc.
  • 3DHISTECH Ltd.
  • Abbott Laboratories
  • Abcam plc
  • AB SCIEX (A Danaher Corporation company)
  • Adaptive Biotechnologies Corporation
  • AdnaGen GmbH (An Alere Company)
  • Advanced Cell Diagnostics
  • Affymetrix, Inc.
  • Agena Bioscience Inc.
  • Agendia BV
  • Agilent Technologies Inc.
  • Amoy Diagnostics Co. Ltd.
  • Angle plc
  • ApoCell, Inc.
  • Apogee Flow Systems Ltd.
  • Apollo PACS, Inc.
  • Applied Cytometry
  • Applied Spectral Imaging, Inc.
  • Arbor Vita Corporation
  • Asuragen, Inc.
  • Aurora Interactive
  • AutoGenomics, Inc.
  • Aviva BioSciences Corporation
  • Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
  • Becton Dickinson and Co. (BD)
  • Biocare Medical, LLC
  • Biocartis S.A.
  • Biocep Ltd
  • Biocept, Inc.
  • Biodot Inc.
  • BioFluidica, Inc.
  • BioGenex
  • BioMarker Strategies
  • bioMérieux SA
  • BioMosaics Inc.
  • Bio-Rad Laboratories, Inc.
  • Bio SB
  • BioTek Instruments, Inc.
  • bioTheranostics (A bioMérieux company)
  • BioView Ltd.
  • Bruker Corporation
  • Cancer Genetics, Inc.
  • Canopus Bioscience Ltd.
  • Caris Life Sciences
  • Carl Zeiss AG
  • Castle Biosciences Inc.
  • CCC Diagnostics, LLC
  • CDx Diagnostics
  • Celerus Diagnostics, Inc.
  • CellaVision AB
  • CellTraffix, Inc.
  • Cellular Dynamics International
  • Celula, Inc.
  • Cernostics
  • Cirdan Imaging Ltd
  • Cisbio Bioassays
  • Clarient Diagnostic Services (A GE Healthcare Company)
  • Clearbridge BioMedics
  • Clontech Laboratories, Inc. (Member of the Takara Bio Group)
  • CombiMatrix Corporation
  • Creatv MicroTech, Inc.
  • Cymogen Dx, LLC (Being Acquired by Biocare Medical LLC)
  • Cynvenio Biosystems, Inc.
  • Cytek Development Inc.
  • CytoTrack ApS
  • Dako A/S (An Agilent Technologies Company)
  • Danaher Corporation
  • Definiens AG
  • DiaCarta Inc.
  • DiaTech Oncology
  • DiscoveRx Corporation
  • Elitech Group
  • EMD Millipore (Merck Millipore)
  • Enzo Biochem, Inc.
  • Epic Sciences, Inc.
  • Fluidigm Corporation
  • Fluxion Biosciences, Inc.
  • Foundation Medicine, Inc.
  • GE Healthcare
  • GeneCentric Diagnostics, Inc.
  • Genomic Health, Inc.
  • HemoGenix
  • HistoGeneX
  • Hologic, Inc.
  • HORIBA Medical
  • HTG Molecular Diagnostics
  • Huron Technologies International Inc.
  • Icellate AB
  • Ikonisys, Inc.
  • ImaBiotech SAS
  • IMMCO Diagnostics (A Trinity Biotech Company)
  • IncellDx, Inc.
  • Indica Labs, Inc.
  • Insight Genetics, Inc.
  • IntelliCyte Corporation
  • Iris BioTechnologies Inc.
  • Janssen Diagnostics
  • Leica Biosystems Inc. (Part of Danaher Corporation)
  • Leica Microsystems (A Danaher Company)
  • LeucoDx Inc.
  • Life Technologies Corporation (Acquired by Thermo Fisher Scientific Inc.)
  • MDxHealth SA
  • Metamark Genetics, Inc.
  • MetaSystems GmbH
  • Miltenyi Biotec GmbH
  • Molecular Devices, LLC (A Danaher Company)
  • MolecularMD Corporation
  • Monogram Biosciences (LabCorp Specialty Testing Group)
  • Multiplicom N.V.
  • Myriad Genetics, Inc.
  • NanoString Technologies, Inc.
  • Nikon Corporation/Nikon Instruments Inc.
  • Nodality, Inc.
  • Norchip AS
  • Olympus Group
  • Omnyx
  • OncoHealth Corp.
  • OncoPlex Diagnostics (OncoPlexDx)
  • Oxford Cancer Biomarkers Ltd.
  • Oxford Gene Technology
  • Panagene Inc.
  • PerkinElmer, Inc.
  • Protea Biosciences Group, Inc.
  • Qiagen N.V.
  • QuanDx
  • QuantuMDx Group
  • Rarecells SAS
  • Response Genetics, Inc.
  • Rheonix, Inc.
  • Roche Diagnostics
  • ScreenCell
  • Siemens Healthcare Diagnostics
  • Sigma-Aldrich Corporation
  • Silicon Biosystems
  • Sony Biotechnology Inc.
  • Span Diagnostics Ltd.
  • Sysmex Corporation
  • TeloVISION, LLC
  • Theranostics Health Inc.
  • Thermo Fisher Scientific, Inc.
  • Ventana Medical Systems Inc. (Member of the Roche Group)
  • Veracyte, Inc.
  • Vitatex Inc.
  • WaveSense, Inc.

Market analyses in this report cover world markets for tissue and cell diagnostics. However, the reader will find a bias toward the developed areas of the globe -- North America, Japan and Western Europe, the areas in which most tissue and cell diagnostic testing is currently performed. The information presented is derived from publicly available information sources such as company reports and announcements, government reports and databases, medical organization reports, medical associations, and other publications. The analysis is based on the author's industry knowledge combined with literature searches and discussions with industry professionals and experts in the areas of point-of-care tests, decentralized healthcare and healthcare economics.

Table of Contents

ONE: EXECUTIVE SUMMARY

  • Overview
  • Scope and Methodology
  • Market Overview
  • Future Prospects in the Tissue and Cell Diagnostics Market

TWO: INTRODUCTION

  • Overview of Tissue and Cell Diagnostics
  • Histology and Cytology
  • Tissue and Cell Diagnostics
  • Point-of-View

THREE: TISSUE AND CELL ANALYSIS TECHNOLOGIES

  • Types of Specimens
  • Microscopy
  • Cell-Based Assays; Cellular Imaging Systems and High Content Screening (HCS)
  • Hematology Analyzers
  • Stains
  • Antibody-Based Technologies
  • Immunohistochemistry (IHC)
  • Flow Cytometry
  • Chromosome Analysis (Karyotyping)
  • Molecular Diagnostic Analysis of Tissues and Nucleic Acid from Tissues
  • Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
  • Polymerase Chain Reaction (PCR) to Detect Biomarkers in Tissue Specimens
  • Analysis of Gene Expression Patterns (“Gene Signatures”)
  • Next Generation Sequencing
  • Tissue Microarrays
  • Circulating Tumor Cells (CTCs)
  • Digital Pathology and Image Cytometry
  • Histology Laboratory Automation
  • Mass Spectrometry - Imaging and Analysis of DNA

FOUR: TISSUE AND CELL DIAGNOSTICS APPLICATIONS

  • Research, Drug Discovery and Development
  • In Vitro Diagnostics

FIVE: DISEASE APPLICATIONS - TISSUE AND CELL DIAGNOSTICS

  • Cancer
  • Cancer Screening - Pap Smear and Human Papillomavirus (HPV) Testing
  • Diagnosis of Cancer
  • Pharmacodiagnostics
  • Prenatal Testing
  • Other Disease Applications of Tissue and Cell Diagnostics

SIX: DEALS - TISSUE AND CELL DIAGNOSTIC COMPANIES

  • Investments and Financing Agreements for Tissue and Cell Diagnostic Companies
  • Agreements with Other Companies
  • Acquisitions of Tissue and Cell Diagnostics Companies
  • Selected Other Agreements

SEVEN: TISSUE/CELL DIAGNOSTICS - MARKET DRIVERS AND CHALLENGES

  • Tissue/Cell Diagnostics Market Drivers
  • Issues and Hurdles Faced by Companies Selling to the Research Market
  • Issues and Hurdles Faced by In Vitro Diagnostic Companies
  • Increasing Numbers of Tests on Small Biopsy Specimens
  • Future Prospects

EIGHT: MARKET ANALYSIS

  • Tissue and Cell Diagnostics Market by Technology
  • Tissue and Cell Diagnostics Market by Geographical Distribution
  • Tissue and Cell Diagnostics Market by Disease Indication
  • Tissue and Cell Diagnostics - Proprietary Tests from Companies with CLIA-Certified
  • Laboratories
  • Analysis of Tissues and Cells in the Life Sciences
  • Prospects for Growth of the Tissue and Cell Diagnostics Market

NINE: COMPANY PROFILES: COMPANIES MARKETING OR DEVELOPING TISSUE DIAGNOSTIC PRODUCTS OR SERVICES

  • 20/20 GeneSystems, Inc
  • 3DHISTECH Ltd
  • Abbott Laboratories
  • Recent Revenue History
  • Company Overview (Focusing on Diagnostics, Especially Immunoassays)
  • Abcam plc
  • Recent Revenue History
  • Company Overview
  • AB SCIEX (A Danaher Corporation Company)
  • Adaptive Biotechnologies Corporation
  • Adnagen GmbH (An Alere Company)
  • Advanced Cell Diagnostics
  • Affymetrix, Inc.
  • Recent Revenue History
  • Company Overview (Focusing on Proteomics Activities)
  • Agena Bioscience Inc.
  • Agendia NV
  • Agilent Technologies Inc.
  • Recent Revenue History
  • Company Overview
  • Amoy Diagnostics Co., Ltd.
  • ANGLE plc
  • ApoCell, Inc.
  • Apogee Flow Systems Ltd.
  • Apollo PACS, Inc.
  • Applied Cytometry
  • Applied Spectral Imaging, Inc.
  • Arbor Vita Corporation
  • Asuragen, Inc.
  • Diagnostic Products
  • Clinical Lab
  • Genomic Services
  • Companion Diagnostics
  • Aurora Interactive
  • AutoGenomics, Inc.
  • Aviva BioSciences Corporation
  • Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
  • Recent Revenue History
  • Company Overview
  • Hematology
  • Flow Cytometry
  • Becton, Dickinson and Company (BD)
  • Recent Revenue History
  • Company Overview
  • Biocare Medical, LLC
  • Biocartis SA
  • BioCEP Ltd
  • Biocept, Inc.
  • BioDot Inc.
  • BioFluidica, Inc
  • BioGenex
  • BioMarker Strategies
  • bioMérieux SA
  • Recent Revenue History
  • Company Overview
  • BioMosaics Inc.
  • Bio-Rad Laboratories, Inc.
  • Recent Revenue History
  • Company Overview
  • Bio SB
  • BioTek Instruments, Inc.
  • bioTheranostics (A bioMérieux Company)
  • BioView Ltd.
  • Bruker Corporation
  • Recent Revenue History
  • Company Overview
  • Cancer Genetics, Inc.
  • Recent Revenue History
  • Company Overview
  • Canopus Bioscience Ltd.
  • Caris Life Sciences
  • Carl Zeiss AG
  • Carl Zeiss Microscopy GmbH
  • Recent Revenue History
  • Company Overview
  • Castle Biosciences Inc.
  • CCC Diagnostics, LLC
  • CDx Diagnostics
  • Celerus diagnostics, Inc.
  • CellaVision AB
  • CellTraffix, Inc.
  • Cellular Dynamics International
  • Celula, Inc.
  • Cernostics
  • Cirdan Imaging Ltd
  • Cisbio Bioassays
  • Clarient Diagnostic Services, Inc. (A GE Healthcare Company)
  • Clearbridge BioMedics
  • Clontech Laboratories, Inc (Member of the Takara Bio Group)
  • CombiMatrix Corporation
  • Recent Revenue History
  • Company Overview
  • Creatv MicroTech, Inc.
  • CymoGen Dx, LLC (Being Acquired by Biocare Medical, LLC)
  • Cynvenio Biosystems, Inc.
  • Cytek Development Inc.
  • CytoTrack ApS
  • Dako A/S (An Agilent Company)
  • Recent Revenue History
  • Company Overview
  • Danaher Corporation
  • Recent Revenue History
  • Company Overview
  • Definiens AG
  • DiaCarta Inc.
  • DiaTech Oncology
  • DiscoveRx Corporation
  • ELITech Group
  • EMD Millipore (Merck Millipore)
  • Recent Revenue History
  • Company Overview
  • Enzo Biochem, Inc
  • Enzo Life Sciences, Inc
  • Enzo Clinical Labs, Inc.
  • Recent Revenue History
  • Company Overview
  • Epic Sciences, Inc.
  • Fluidigm Corporation
  • Recent Revenue History
  • Company Overview
  • Fluxion Biosciences, Inc.
  • Foundation Medicine, Inc.
  • Recent Revenue History
  • Company Overview
  • GE Healthcare
  • Recent Revenue History
  • Company Overview
  • GeneCentric Diagnostics, Inc.
  • Genomic Health, Inc.
  • Recent Revenue History
  • Company Overview
  • HemoGenix
  • HistoGeneX
  • Hologic, Inc.
  • Recent Revenue History
  • Company Overview
  • HORIBA Medical
  • Recent Revenue History
  • Company Overview
  • HTG Molecular Diagnostics
  • Huron Technologies International Inc.
  • Icellate AB
  • Ikonisys, Inc.
  • ImaBiotech SAS
  • ImaBiotech Corp
  • IMMCO Diagnostics, Inc. (A Trinity Biotech Company)
  • IncellDx, Inc.
  • Indica Labs, Inc.
  • Insight Genetics, Inc.
  • IntelliCyt Corporation
  • Iris BioTechnologies Inc.
  • Recent Revenue History
  • Company Overview
  • Janssen Diagnostics
  • Janssen Diagnostics BVBA
  • Janssen Diagnostics, LLC (Oncology Diagnostics)
  • Leica Biosystems Inc. (Part of Danaher Corporation)
  • Leica Microsystems (A Danaher Company)
  • LeucoDx Inc.
  • Life Technologies Corporation (Acquired by Thermo Fischer Scientific Inc.)
  • Recent Revenue History
  • Company Overview
  • MDxHealth SA
  • Recent Revenue History
  • Company Overview
  • Metamark Genetics, Inc.
  • MetaSystems GmbH
  • MetaSystems Group, Inc.
  • Miltenyi Biotec GmbH
  • Molecular Devices, LLC (A Danaher Company)
  • MolecularMD Corporation
  • Monogram Biosciences (LabCorp Specialty Testing Group)
  • Multiplicom NV
  • Myriad Genetics, Inc.
  • Recent Revenue History
  • Company Overview
  • NanoString Technologies, Inc.
  • Recent Revenue History
  • Company Overview
  • Nikon Corporation
  • Nikon Instruments Inc.
  • Recent Revenue History
  • Company Overview
  • Nodality, Inc.
  • Norchip AS
  • Olympus Group
  • Recent Revenue History
  • Company Overview
  • Omnyx
  • OncoHealth Corp.
  • OncoPlex Diagnostics (OncoPlexDx)
  • Oxford Cancer Biomarkers Ltd
  • Oxford Gene Technology
  • Panagene Inc.
  • PerkinElmer, Inc.
  • Recent Revenue History
  • Company Overview
  • Quantitative Pathology Imaging and Analysis Systems
  • Cellular Imaging and Analysis Systems
  • Histological Analysis
  • Protea Biosciences Group, Inc.
  • Recent Revenue History
  • Company Overview
  • QIAGEN N.V.
  • Recent Revenue History
  • Company Overview
  • QuanDx
  • QuantuMDx Group
  • Rarecells SAS
  • Response Genetics, Inc.
  • Recent Revenue History
  • Company Overview
  • Rheonix, Inc.
  • Roche Diagnostics
  • Recent Revenue History
  • Company Overview
  • ScreenCell
  • Siemens Healthcare Diagnostics
  • Recent Revenue History
  • Company Overview
  • Sigma-Aldrich Corporation
  • Recent Revenue History
  • Company Overview
  • Silicon Biosystems
  • Sony Biotechnology Inc.
  • Span Diagnostics Ltd.
  • Sysmex Corporation
  • Recent Revenue History
  • Company Overview
  • TeloVISION, LLC
  • Theranostics Health Inc.
  • Thermo Fisher Scientific, Inc.
  • Recent Revenue History
  • Company Overview
  • Ventana Medical Systems, Inc. (Member of the Roche Group)
  • Veracyte, Inc.
  • Recent Revenue History
  • Company Overview
  • Vitatex Inc.
  • WaveSense, Inc.
Back to Top